More on TEM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $63.81 |
|
|||
| Open | $63.94 | ||||
| 52 Wk High | $0.45 | ||||
| 52 Wk Low | $0.37 | ||||
| Day High | $68.15 | ||||
| Day Low | $62.67 | ||||
| P/E | N/A | ||||
| EPS | $-0.31 | ||||
| Volume | 4,688,229 | ||||
- Tempus AI signs multi-year oncology data deal with Bristol Myers Squibb
- Pathos AI strikes deals with Bristol Myers Squibb and Tempus AI
- Form 8-K Tempus AI, Inc. For: Oct 23
- Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development
- Tempus Expands Strategic Collaboration with Bristol Myers Squibb
- Pathos AI Announces Strategic Collaborations with Bristol Myers Squibb and Tempus AI to Advance AI-Driven Drug Development Beginning with Alzheimer’s Disease and Other Neurological Conditions
- Form EFFECT Tempus AI, Inc.
- Form 424B3 Tempus AI, Inc.
- Form S-4/A Tempus AI, Inc.
- Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC
Entities mentioned with TEM
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- James Beeland Rogers Jr. | View Related Stories »
- Twitter | View Related Stories »
- Show More...
